Leadership Team
Making cancer more detectable.
Robert Proulx
Executive Chairman
Robert is an operationally oriented executive with over 30 years in life science & medical device product development & commercialization and has led the company through recent restructuring and recapitalization efforts.
Ward Detwiller
Chief Business Officer
Experienced early stage technology executive with a track record of bringing health technologies from concept to market.
Melanie Leydin CA FGIA
Company Secretary
Melanie is a Chartered Accountant and a Fellow of the Governance Institute of Australia with over 30 years of experience in accounting and over 20 years in Board positions, currently the Managing Director of Vistra Australia.
Michael Harsh
Non-Executive Director
Mike has over 36 years of experience in healthcare technology, focused on diagnostic imaging having served as Vice President and Chief Technology Officer for GE Healthcare.
David Ludvigson
Non-Executive Director
David is a financial and operating executive with over 35 years of international experience in life sciences and technology companies including IDEC Pharmaceuticals, Matrix Pharmaceutical, Nanogen, and MIPS Computer Systems.
Mark Van Asten
Non-Executive Director
Mark has over 30 years of experience in the medical diagnostics and life science industry. Much of this time has been specific to international business development, strategic planning and introduction of new technology.
Brett Mitchell
Non-Executive Director
Mr. Mitchell is an experienced corporate finance executive with over 25 years of experience in the venture capital and equity capital markets, leading transactions in the mining, energy, technology and life sciences sectors.
Scientific Advisory
Collective expertise in oncology, medical imaging, nanotechnology, clinical trial design.
Please select listing to show.
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.